Biomarkers and Alzheimer’s

A number of breakout sessions today focused on biomarkers and personalized medicine. A very compelling session was on Biomarkers and Diagnostics in Alzheimer’s. It my impression that one of the major hurdles in the adoption of biomarker technology is the conception that its simply “diagnostics.” The current system is designed to reimburse based on the [...]

25th anniversary of the Orphan Drug Act

We celebrated the 25th anniversary of the Orphan Drug Act yesterday with a breakout session in the morning and a press conference in the afternoon. Speakers included the legislators who championed the bill 25 years ago and companies who are now, thanks to the Act, able to make treatments that change people’s lives.
The Orphan Drug [...]

A day for the people, and the animals too

This year’s BIO Internation Convention centre is big - expect to get a little lost the first few times you enter the labyrinth - and the first day is always a little crazy, with 22,000 + delegates in one location that’s just part of the fun. But down to business: today’s breakout session tracks included [...]

Follow-On Biologics

Well, its official – Day 1 of the 2008 BIO International Convention has begun! We kicked off this morning with a Super Session on Follow-On Biologics – a hot topic drawing a sizeable crowd and a great interactive Q&A. The panelists presented both the innovator and follow-on biologic perspectives on scientific and regulatory issues.
But the [...]